$YHGJ
YUNHONG GREEN CTI LTD.

2023 Q1 Form 10-K Financial Statement

#000149315223011960 Filed on April 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $5.051M $5.570M $18.05M
YoY Change -12.87% 35.52% -25.07%
Cost Of Revenue $3.924M $4.516M $14.91M
YoY Change -17.53% 56.82% -26.63%
Gross Profit $1.127M $1.054M $3.138M
YoY Change 8.47% -14.34% -16.64%
Gross Profit Margin 22.31% 18.92% 17.39%
Selling, General & Admin $993.0K $1.092M $3.856M
YoY Change 13.49% 127.35% -2.3%
% of Gross Profit 88.11% 103.61% 122.88%
Research & Development $200.0K
YoY Change -2.91%
% of Gross Profit 6.37%
Depreciation & Amortization $80.00K $92.00K $383.0K
YoY Change -18.37% 37.27% -17.1%
% of Gross Profit 7.1% 8.73% 12.21%
Operating Expenses $1.115M $1.092M $4.258M
YoY Change 5.39% 127.35% -0.28%
Operating Profit $12.00K -$38.00K -$1.120M
YoY Change -163.16% -105.07% 121.39%
Interest Expense $142.0K -$125.0K $450.0K
YoY Change 47.92% -97.88% -20.27%
% of Operating Profit 1183.33%
Other Income/Expense, Net $384.0K $85.00K -$347.0K
YoY Change -19300.0% -80.35% -95.2%
Pretax Income $396.0K -$78.00K -$1.467M
YoY Change -1985.71% -99.14% -81.02%
Income Tax $0.00
% Of Pretax Income
Net Earnings $23.00M -$112.0K $24.00M
YoY Change -109623.81% -98.76% -390.12%
Net Earnings / Revenue 455.36% -2.01% 132.98%
Basic Earnings Per Share $0.02 -$0.22
Diluted Earnings Per Share $0.02 -$0.01 -$0.22
COMMON SHARES
Basic Shares Outstanding 19.97M shares 16.06M shares 9.302M shares
Diluted Shares Outstanding 17.69M shares 9.302M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.0K $146.0K $146.0K
YoY Change -37.5% 121.21% 121.21%
Cash & Equivalents $130.0K $146.0K $146.0K
Short-Term Investments
Other Short-Term Assets $489.0K $389.0K
YoY Change 103.75% -64.28%
Inventory $7.944M $8.325M $8.325M
Prepaid Expenses $489.0K $389.0K
Receivables $3.344M $1.618M $1.618M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.91M $10.48M $10.48M
YoY Change -7.75% -16.0% -16.0%
LONG-TERM ASSETS
Property, Plant & Equipment $898.0K $922.0K $4.804M
YoY Change -16.54% -19.34% 2.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $4.655M $4.804M $4.804M
YoY Change -13.04% -0.08% -0.08%
TOTAL ASSETS
Total Short-Term Assets $11.91M $10.48M $10.48M
Total Long-Term Assets $4.655M $4.804M $4.804M
Total Assets $16.56M $15.28M $15.28M
YoY Change -9.3% -11.57% -11.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.278M $1.313M $1.313M
YoY Change -45.55% -38.41% -38.41%
Accrued Expenses $1.382M $2.480M $2.998M
YoY Change 184.95% 283.31% 127.64%
Deferred Revenue
YoY Change
Short-Term Debt $4.284M $2.878M $2.878M
YoY Change -16.94% -42.47% -42.47%
Long-Term Debt Due $1.826M $3.166M $289.0K
YoY Change 697.38% -54.26% -84.94%
Total Short-Term Liabilities $9.288M $7.478M $7.478M
YoY Change 6.53% -27.9% -27.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.694M $1.694M
YoY Change -100.0%
Other Long-Term Liabilities $3.239M $3.364M $3.364M
YoY Change -14.24% 17.62%
Total Long-Term Liabilities $3.239M $5.058M $5.058M
YoY Change -40.9% 76.85% 76.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.288M $7.478M $7.478M
Total Long-Term Liabilities $3.239M $5.058M $5.058M
Total Liabilities $12.53M $12.54M $12.54M
YoY Change -11.78% -5.25% -5.25%
SHAREHOLDERS EQUITY
Retained Earnings -$23.72M -$24.12M
YoY Change 4.62% 6.48%
Common Stock $27.92M $25.18M
YoY Change 49.43% 33.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $161.0K $161.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares 43.66K shares
Shareholders Equity $4.035M $2.746M $2.746M
YoY Change
Total Liabilities & Shareholders Equity $16.56M $15.28M $15.28M
YoY Change -9.3% -11.57% -11.57%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $23.00M -$112.0K $24.00M
YoY Change -109623.81% -98.76% -390.12%
Depreciation, Depletion And Amortization $80.00K $92.00K $383.0K
YoY Change -18.37% 37.27% -17.1%
Cash From Operating Activities -$1.369M $1.181M $2.368M
YoY Change -68550.0% -253.26% -163.83%
INVESTING ACTIVITIES
Capital Expenditures $56.00K $42.00K $163.0K
YoY Change -473.33% -281.19% -233.61%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$56.00K -$42.00K -$163.0K
YoY Change 273.33% 81.19% -104.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $45.00K
YoY Change
Cash From Financing Activities $1.409M -1.094M -$2.125M
YoY Change 809.03% -185.75% -439.48%
NET CHANGE
Cash From Operating Activities -$1.369M 1.181M $2.368M
Cash From Investing Activities -$56.00K -42.00K -$163.0K
Cash From Financing Activities $1.409M -1.094M -$2.125M
Net Change In Cash -$16.00K 45.00K $80.00K
YoY Change -111.27% -90.66% -131.21%
FREE CASH FLOW
Cash From Operating Activities -$1.369M $1.181M $2.368M
Capital Expenditures $56.00K $42.00K $163.0K
Free Cash Flow -$1.425M $1.139M $2.205M
YoY Change -8482.35% -252.39% -161.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 CTIB Accrued Deemed Dividends
AccruedDeemedDividends
usd
CY2021 CTIB Accrued Deemed Dividends Two
AccruedDeemedDividendsTwo
usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
usd
CY2022 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
CY2022 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2021 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001042187
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q4 CTIB Other Assets Noncurrent Excluding Property Plant And Equipment
OtherAssetsNoncurrentExcludingPropertyPlantAndEquipment
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2021 CTIB Accrued Deemed Dividends Three
AccruedDeemedDividendsThree
usd
CY2021 CTIB Stock Issued During Period Value Completion Of Hfs
StockIssuedDuringPeriodValueCompletionOfHfs
usd
CY2022 CTIB Accrued Deemed Dividends
AccruedDeemedDividends
usd
CY2022 CTIB Accrued Deemed Dividends One
AccruedDeemedDividendsOne
usd
CY2022 CTIB Accrued Deemed Dividends Two
AccruedDeemedDividendsTwo
usd
CY2022 CTIB Accrued Deemed Dividends Three
AccruedDeemedDividendsThree
usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
usd
CY2022 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 CTIB Impairment Of Note Receivable
ImpairmentOfNoteReceivable
usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2022 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2022 CTIB Change In Deferred Financing Costs
ChangeInDeferredFinancingCosts
usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2021 CTIB Conversion Series C And D Preferred Stock
ConversionSeriesCAndDPreferredStock
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 CTIB Amortization Of Beneficial Conversion Feature And Deemed Dividend On Series C Preferred Stock
AmortizationOfBeneficialConversionFeatureAndDeemedDividendOnSeriesCPreferredStock
usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 CTIB Effective Income Tax Rate Reconciliation Nol Carryback Claim Cares Act Amount
EffectiveIncomeTaxRateReconciliationNOLCarrybackClaimCARESActAmount
usd
CY2021 CTIB Effective Income Tax Rate Reconciliation Nol Carryback Claim Cares Act Amount
EffectiveIncomeTaxRateReconciliationNOLCarrybackClaimCARESActAmount
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
usd
CY2022Q4 CTIB Deferred Tax Assets Deconsolidation And Impairment
DeferredTaxAssetsDeconsolidationAndImpairment
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
usd
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2022 CTIB Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entities
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntities
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-23115
CY2022 dei Entity Registrant Name
EntityRegistrantName
YUNHONG CTI LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2848943
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
22160 N. Pepper Road
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Lake Barrington
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60010
CY2022 dei City Area Code
CityAreaCode
(847)
CY2022 dei Local Phone Number
LocalPhoneNumber
382-1000
CY2022 dei Security12b Title
Security12bTitle
Common Stock, no par value per share
CY2022 dei Trading Symbol
TradingSymbol
CTIB
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3912000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19971755 shares
CY2021 dei Auditor Firm
AuditorFirmId
587
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2021 dei Auditor Name
AuditorName
RBSM LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1618000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3443000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8325000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
7876000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
389000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
625000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
464000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10478000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12474000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17723000 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17470000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2084000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2076000 usd
CY2022Q4 CTIB Intellectual Property Gross
IntellectualPropertyGross
783000 usd
CY2021Q4 CTIB Intellectual Property Gross
IntellectualPropertyGross
783000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
39000 usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
23000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
519000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
519000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
108000 usd
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
223000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21256000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21094000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20334000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19951000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
922000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1143000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3882000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3530000 usd
CY2021Q4 CTIB Other Assets Noncurrent Excluding Property Plant And Equipment
OtherAssetsNoncurrentExcludingPropertyPlantAndEquipment
135000 usd
CY2022Q4 CTIB Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
3882000 usd
CY2021Q4 CTIB Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
3665000 usd
CY2022Q4 us-gaap Assets
Assets
15282000 usd
CY2021Q4 us-gaap Assets
Assets
17282000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1313000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2132000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2878000 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5003000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
289000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
726000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1193000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
518000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
670000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2480000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
647000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7478000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10371000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
427000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1267000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3364000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2860000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5058000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2860000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12536000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
13231000 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16102749 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5930408 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16059991 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5886750 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
21283000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
14538000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3895000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4317000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24122000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22655000 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43658 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43658 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
161000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
161000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4051000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4051000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15282000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17282000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18048000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24086000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14910000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20322000 usd
CY2022 us-gaap Gross Profit
GrossProfit
3138000 usd
CY2021 us-gaap Gross Profit
GrossProfit
3764000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3720000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3815000 usd
CY2022 us-gaap Selling Expense
SellingExpense
136000 usd
CY2021 us-gaap Selling Expense
SellingExpense
132000 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
402000 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
323000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
4258000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
4270000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1120000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-506000 usd
CY2022 us-gaap Interest Expense
InterestExpense
450000 usd
CY2021 us-gaap Interest Expense
InterestExpense
564000 usd
CY2021 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
3357000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5885000 usd
CY2021 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-4325000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
103000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
195000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-347000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7222000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1467000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7728000 usd
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1467000 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-7728000 usd
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
174000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1467000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7554000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
718000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1467000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8272000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-388000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-6273000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1467000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1669000 usd
CY2022 CTIB Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature
584000 usd
CY2021 CTIB Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature
3573000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2051000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11845000 usd
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.04
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.01
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.04
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9301888 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5878887 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9301888 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5878887 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1187487 usd
CY2021 CTIB Series D Convertible Preferred Stock Issuance
SeriesDConvertiblePreferredStockIssuance
1500000 usd
CY2021 CTIB Series C Convertible Preferred Stock Issuance
SeriesCConvertiblePreferredStockIssuance
1500000 usd
CY2021 CTIB Series B Convertible Preferred Stock Modification
SeriesBConvertiblePreferredStockModification
1612707 usd
CY2021 CTIB Adjustments To Additional Paid In Capital Preferred Stock With Beneficial Conversion Feature
AdjustmentsToAdditionalPaidInCapitalPreferredStockWithBeneficialConversionFeature
1500000 usd
CY2021 CTIB Deemed Dividend On Beneficial Conversion Feature Of Preferred Stock One
DeemedDividendOnBeneficialConversionFeatureOfPreferredStockOne
-1500000 usd
CY2021 CTIB Accrued Deemed Dividends One
AccruedDeemedDividendsOne
-33611 usd
CY2021 CTIB Adjustments To Additional Paid In Capital Accretion Of Preferred Stock
AdjustmentsToAdditionalPaidInCapitalAccretionOfPreferredStock
-46190 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7554000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5885124 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4051000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4051000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4051000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1467000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1467000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7554000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
383000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
462000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
162000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
501000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
92000 usd
CY2021 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
3357000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40000 usd
CY2021 CTIB Impairment Of Note Receivable
ImpairmentOfNoteReceivable
95000 usd
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-10015000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1825000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1673000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
449000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
604000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-836000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-132000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-501000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-819000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1173000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1897000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2368000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3710000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
163000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
122000 usd
CY2021 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
3500000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-163000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3378000 usd
CY2022 CTIB Repayment Of Debt And Revolving Line Of Credit
RepaymentOfDebtAndRevolvingLineOfCredit
-2125000 usd
CY2021 CTIB Repayment Of Debt And Revolving Line Of Credit
RepaymentOfDebtAndRevolvingLineOfCredit
-8284000 usd
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3000000 usd
CY2021 CTIB Change In Deferred Financing Costs
ChangeInDeferredFinancingCosts
-85000 usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5995000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2125000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
626000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-550000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-256000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
322000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
146000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
375000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
491000 usd
CY2022 CTIB Accrued Dividend On Preferred Stock
AccruedDividendOnPreferredStock
584000 usd
CY2021 CTIB Accrued Dividend On Preferred Stock
AccruedDividendOnPreferredStock
536000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
747000 usd
CY2022 CTIB Conversion Series C And D Preferred Stock
ConversionSeriesCAndDPreferredStock
6745000 usd
CY2021 us-gaap Stock Issued1
StockIssued1
3000000 usd
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
202000 usd
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
206000 usd
CY2021 CTIB Amortization Of Beneficial Conversion Feature And Deemed Dividend On Series C Preferred Stock
AmortizationOfBeneficialConversionFeatureAndDeemedDividendOnSeriesCPreferredStock
2990000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zhssjz9zi6m7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z4UC8ecqi3j6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include valuation allowances for doubtful accounts, inventory valuation, deferred tax assets, goodwill and intangible asset valuation, leasehold assets and liabilities, Preferred Stock deemed dividends and beneficial conversion feature values, and assumptions used as inputs in the Black-Scholes option-pricing model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8159000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8115000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
177000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46000 usd
CY2022Q4 CTIB Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
233000 usd
CY2021Q4 CTIB Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
158000 usd
CY2022Q4 CTIB Deferred Tax Liabilities Section481a Adjustment
DeferredTaxLiabilitiesSection481aAdjustment
-56000 usd
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
108000 usd
CY2021 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
220000 usd
CY2021Q4 CTIB Deferred Tax Liabilities Section481a Adjustment
DeferredTaxLiabilitiesSection481aAdjustment
-112000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
177000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
46000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
400000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1700000 usd
CY2020Q4 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1.00
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
206000 usd
us-gaap Net Income Loss
NetIncomeLoss
24000000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2900000 usd
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6000000.0 usd
CY2022 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
160000 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
123000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1200000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
900000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
900000 usd
CY2022Q4 us-gaap Deferred Income
DeferredIncome
600000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
6000000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
128572 shares
CY2021 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cancelled Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledWeightedAverageExercisePrice
1.75
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1457000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1249000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2513000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2492000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4355000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4135000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8325000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
7876000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
4860000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
6922000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3166000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6922000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1694000 usd
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P1Y
CY2021Q3 CTIB Debt Instrument Renewal Fee Percent
DebtInstrumentRenewalFeePercent
0.0125 pure
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
195160 shares
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-120000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-743000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
25000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-770000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
50000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1792000 usd
CY2022 CTIB Effective Income Tax Rate Reconciliation Deconsolidation And Impairment Amount
EffectiveIncomeTaxRateReconciliationDeconsolidationAndImpairmentAmount
32000 usd
CY2021 CTIB Effective Income Tax Rate Reconciliation Deconsolidation And Impairment Amount
EffectiveIncomeTaxRateReconciliationDeconsolidationAndImpairmentAmount
623000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
77000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
344000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
3241000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2696000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
307000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
308000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
55000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
152000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
205000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2378000 usd
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2360000 usd
CY2022Q4 CTIB Deferred Tax Assets Adjustments
DeferredTaxAssetsAdjustments
233000 usd
CY2021Q4 CTIB Deferred Tax Assets Adjustments
DeferredTaxAssetsAdjustments
282000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-91000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-90000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2000 usd
CY2022Q4 CTIB Deferred Tax Assets Deferred Interest Expense
DeferredTaxAssetsDeferredInterestExpense
1704000 usd
CY2021Q4 CTIB Deferred Tax Assets Deferred Interest Expense
DeferredTaxAssetsDeferredInterestExpense
1578000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
313000 usd
CY2021Q4 CTIB Deferred Tax Assets Deconsolidation And Impairment
DeferredTaxAssetsDeconsolidationAndImpairment
415000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7982000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8069000 usd
CY2022Q4 CTIB Operating Lease Rightofuse Asset Gross
OperatingLeaseRightofuseAssetGross
4805000 usd
CY2021Q4 CTIB Operating Lease Rightofuse Asset Gross
OperatingLeaseRightofuseAssetGross
4031000 usd
CY2022Q4 CTIB Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
923000 usd
CY2021Q4 CTIB Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
501000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3882000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3530000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
518000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
670000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
518000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
670000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3364000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2860000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3364000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2860000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3882000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3530000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1125 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1125 pure
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
746000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
501000 usd
CY2022 us-gaap Lease Cost
LeaseCost
746000 usd
CY2021 us-gaap Lease Cost
LeaseCost
501000 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
195160 shares
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
949000 usd
CY2022Q4 CTIB Lessee Operating Lease Liability To Be Paid Year Two And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearTwoAndThereafter
5074000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6023000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2141000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3882000 usd
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1828572 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1828572 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P4Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
160000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2021 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
1.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
128572 shares
CY2021Q4 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1.75
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
128572 shares
CY2022Q4 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1.75
CY2022Q4 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
128572 shares
CY2022Q4 CTIB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
1.75
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1828572 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1828572 shares
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1467000 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-7728000 usd
CY2021 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
718000 usd
CY2022 CTIB Deemed Dividends On Preferred Stock And Amortization Of Benefit Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBenefitConversionFeature
584000 usd
CY2021 CTIB Deemed Dividends On Preferred Stock And Amortization Of Benefit Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBenefitConversionFeature
3573000 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2051000 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10323000 usd
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
174000 usd
CY2021 CTIB Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entities
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntities
-11845000 usd
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.04
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9301888 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5878887 shares
CY2022Q2 CTIB Notice Deficiency Description
NoticeDeficiencyDescription
During May 2022 the Company received a notice of deficiency from the NASDAQ related to a failure to maintain a $1 bid price during a 30 day period. The Company had to achieve a $1 bid price for no fewer than ten (10) consecutive trading days during a 180 day grace period in order to regain compliance. During November, 2022, the Company had not regained compliance with the minimum bid price requirement which caused the NASDAQ to send the Company a delisting letter, subject to appeal. The Company filed a timely appeal, which was heard by a Hearing Panel on January 5, 2023. Consistent with the outcome of that Hearing, and in light of the recovery in the Company’s bid price, on January 19, 2023, the NASDAQ informed the Company that it had regained compliance with this standard.
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18048000 usd
CY2022 CTIB Revenue From Contract With Customer Including Assessed Tax Percentage From Total Revenue
RevenueFromContractWithCustomerIncludingAssessedTaxPercentageFromTotalRevenue
1 pure
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24085666 usd
CY2021 CTIB Revenue From Contract With Customer Including Assessed Tax Percentage From Total Revenue
RevenueFromContractWithCustomerIncludingAssessedTaxPercentageFromTotalRevenue
1 pure
CY2022 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p id="xdx_804_eus-gaap--LossContingencyDisclosures_zkpIZVbQBjT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_828_z8ILfV7fcMki">Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary conduct of our business, we are from time to time subject to lawsuits, investigations and claims, including environmental claims and employee-related matters. Although we cannot predict with certainty the ultimate resolution of lawsuits, investigations and claims asserted against us, including civil penalties or other enforcement actions, we do not believe that any currently pending legal proceeding or proceedings to which we are a party will have a material adverse effect on our business, financial condition or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

Files In Submission

Name View Source Status
0001493152-23-011960-index-headers.html Edgar Link pending
0001493152-23-011960-index.html Edgar Link pending
0001493152-23-011960.txt Edgar Link pending
0001493152-23-011960-xbrl.zip Edgar Link pending
ctib-20221231.xsd Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ctib-20221231_def.xml Edgar Link unprocessable
ctib-20221231_pre.xml Edgar Link unprocessable
ctib-20221231_cal.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctib-20221231_lab.xml Edgar Link unprocessable